Chest, Vol 98, 325-330, Copyright © 1990 by American College of Chest Physicians

ARTICLES

Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA

BA Phillips, FA Schmitt, DT Berry, DG Lamb, M Amin and YR Cook
Department of Medicine and Neurology, University of Kentucky College of Medicine, Lexington.

Nasal CPAP is presently accepted as first-line therapy for obstructive sleep apnea, but a significant minority of patients do not tolerate nasal CPAP. The purpose of this study was to compare the benefits of nasal CPAP, nasal oxygen (O2), and placebo (air) using patients as their own controls. We studied eight men, aged 33 to 72 (mean 57 years), who had mild obstructive sleep apnea. To be eligible for study, patients had to have an apnea plus hypopnea index greater than or equal to 5, plus one or more of the following: blood pressure greater than 150/95 mm Hg, multiple sleep latency test mean score less than or equal to 10 minutes, or significant nocturnal cardiac ectopy. After a baseline study, patients received a month each of nocturnal O2 at 4 LPM and air at 4 LPM, presented in random order. The third month of treatment consisted of nasal CPAP (range 2.5 to 12.5 cm H2O). Patients underwent evaluation at baseline and after each month of treatment. It was concluded that oxygen was more effective in improving oxygenation and hypopneas than is nasal CPAP. However, oxygen did not reduce apneas or improve daytime hypersomnolence as well as nasal CPAP in patients with mild OSA. Oxygen might be considered as an alternate form of treatment for patients who are not hypersomnolent, or as an adjunct to nasal CPAP.

This article has been cited by other articles:

				P. Haentjens, A. Van Meerhaeghe, A. Moscariello, S. De Weerdt, K. Poppe, A. Dupont, and B. Velkeniers The Impact of Continuous Positive Airway Pressure on Blood Pressure in Patients With Obstructive Sleep Apnea Syndrome: Evidence From a Meta-analysis of Placebo-Controlled Randomized Trials Arch Intern Med, April 23, 2007; 167(8): 757 - 764. [Abstract] [Full Text] [PDF]

				P. J. Mills, B. P. Kennedy, J. S. Loredo, J. E. Dimsdale, and M. G. Ziegler Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea J Appl Physiol, January 1, 2006; 100(1): 343 - 348. [Abstract] [Full Text] [PDF]

				E. J. Sherman, D. M. Rubin, E. Venkatraman, G. K. Schwartz, V. A. Miller, M. H. Radzyner, H. S. Ruchlin, D. Spriggs, and D. G. Pfister Using Patients As Their Own Controls for Cost Evaluation of Phase I Clinical Trials J. Clin. Oncol., April 1, 2004; 22(7): 1308 - 1314. [Abstract] [Full Text] [PDF]

				S. R. Patel, D. P. White, A. Malhotra, M. L. Stanchina, and N. T. Ayas Continuous Positive Airway Pressure Therapy for Treating gess in a Diverse Population With Obstructive Sleep Apnea: Results of a Meta-analysis Arch Intern Med, March 10, 2003; 163(5): 565 - 571. [Abstract] [Full Text] [PDF]

				H. Schneider, C. D. Schaub, C. A. Chen, K. A. Andreoni, A. R. Schwartz, P. L. Smith, J. L. Robotham, and C. P. O'Donnell Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea J Appl Physiol, March 1, 2000; 88(3): 1093 - 1102. [Abstract] [Full Text] [PDF]

				J. S. Loredo, S. Ancoli-Israel, and J. E. Dimsdale Effect of Continuous Positive Airway Pressure vs Placebo Continuous Positive Airway Pressure on Sleep Quality in Obstructive Sleep Apnea* Chest, December 1, 1999; 116(6): 1545 - 1549. [Abstract] [Full Text] [PDF]

				P. Meek Dyspnea . Mechanisms, Assessment, and Management: A Consensus Statement Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 321 - 340. [Full Text]

				H. Kim, T Young, C. Matthews, S. Weber, A. Woodward, and M Palta Sleep-disordered breathing and neuropsychological deficits. A population-based study Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1813 - 1819. [Abstract] [Full Text]